Join Eileen Smith, MBA, CNMT, for an informative discussion on the phases of drug development. Investigational drugs, including imaging biomarkers, must navigate through specific phases before they can be cleared for approval by the FDA for clinical use. You'll hear how and why these phases were developed, what each phase entails and their overall impact on drug development. Register today!